Boardroom Alpha
Meeting calendar
SIBN · Annual meeting · Thursday, June 4, 2026

Si-bone Inc

2 nominees · 3 ballot items.

Three proposals: (1) election of two director nominees to the Board, (2) ratification of PricewaterhouseCoopers LLP as the company’s independent registered public accounting firm for 2026, and (3) an advisory (non-binding) 'say-on-pay' vote to approve the compensation of the named executive officers as disclosed in the proxy statement.

Market cap
$771M
1Y TSR
-4.5%
Board grade
C+
Record date
Apr 6, 2026
Filing
DEF 14A
Meeting concluded · Jun 4, 2026

Follow how the vote landed and what changed on Si-bone Inc’s board — director track records, governance grades, and ongoing monitoring — on the Boardroom Alpha platform.

Proposals

On the ballot3

  1. 1

    Election of Directors

    ManagementBoard: FOR

    Elect two Board-nominated directors (Jeffrey W. Dunn and John G. Freund, M.D.) to serve three-year terms expiring in 2029.

  2. 2

    Ratification of Selection of Independent Registered Public Accounting Firm

    ManagementBoard: FOR

    Ratify the Audit Committee’s selection of PricewaterhouseCoopers LLP as SI‑BONE’s independent registered public accounting firm for the fiscal year ending December 31, 2026.

  3. 3

    Advisory, Non-Binding Vote on Executive Compensation (Say-on-Pay

    ManagementBoard: FOR

    Advisory, non-binding vote to approve the compensation of the named executive officers as disclosed in the proxy statement (Item 402 of Regulation S-K).

    More detail

    This proposal asks stockholders to cast a non-binding advisory vote to approve the company’s named executive officer compensation as disclosed in the proxy (a standard 'say-on-pay' proposal). Management is seeking shareholder approval to affirm its compensation philosophy and pay decisions, which emphasize pay-for-performance through a mix of base salary, annual cash incentives tied to financial and operational metrics, time‑vested RSUs, and performance-based PSUs (including new Financial PSUs for the CEO tied to Revenue Growth and Adjusted EBITDA and relative TSR PSUs). The proxy highlights material 2025 outcomes—~20% revenue growth, positive Adjusted EBITDA of $8.9 million, and the introduction of Financial PSUs—linking higher performance payouts to the achievement of those metrics, and discloses target and realized compensation for named executives. The Board recommends a vote in favor on the basis that the program aligns management’s incentives with long‑term stockholder value, incorporates stockholder feedback (including increased emphasis on financial metrics), and uses multi-year vesting and performance measures to promote retention and sustained performance. The vote is advisory and non-binding; nevertheless, the Board and the Compensation Committee state they will consider the vote results in future compensation decisions. The proxy also notes strong prior support (approximately 98.3% approval in 2025) and active stockholder engagement during 2025, which the Compensation Committee cites as validation of its approach and as informing recent program changes. Potential governance considerations include the balance between TSR-based rewards and internal financial metrics, the concentration of realized pay in equity awards (which depend on market performance), and the presence of severance/change-in-control protections; analysts should weigh whether these design features sufficiently mitigate risk and align pay with sustained value creation. In summary, the Board frames the proposal as a confirmation of a pay structure it believes to be competitive, retention‑oriented, and increasingly tied to measurable financial and market performance, while reserving the right to adjust programs in response to stockholder feedback and future performance outcomes.

Director elections

Nominees on the ballot2

Independent
Tenure on this board
13.5 yrs
Also a director at
Collegium Pharmaceutical Inc (COLL)
Ownership

Top institutional holders10

Latest 13F quarter
1First Light Asset Management, LLC12.1%5,353,190$68M
2AMERICAN CENTURY COMPANIES INC5.7%2,509,065$32M
3BROWN ADVISORY INC4.6%2,024,082$26M
4CADIAN CAPITAL MANAGEMENT, LP4.3%1,887,472$24M
5VANGUARD CAPITAL MANAGEMENT LLC4.0%1,764,313$22M
6Granahan Investment Management, LLC3.9%1,739,097$22M
7BlackRock, Inc.3.7%1,630,107$21M
8Impax Asset Management Group plc3.2%1,425,010$18M
9BlackRock, Inc.2.9%1,276,115$16M
10SILVERCREST ASSET MANAGEMENT GROUP LLC2.8%1,244,584$16M
Filings

Recent key filings

Periodic reports
Definitive proxies
Reference

Frequently asked questions

When is the Si-bone Inc 2026 annual meeting?
Si-bone Inc (SIBN) holds its 2026 annual shareholder meeting on Thursday, June 4, 2026.
What is the record date for the Si-bone Inc 2026 meeting?
The record date for the Si-bone Inc 2026 meeting is Monday, April 6, 2026. Shareholders of record on or before that date are eligible to vote.
Who are the director nominees for Si-bone Inc's 2026 meeting?
The board is presenting 2 director nominees at the Si-bone Inc 2026 meeting, listed with their independence status and background.
What proposals will shareholders vote on at the Si-bone Inc 2026 meeting?
Shareholders will vote on 3 proposals at the Si-bone Inc 2026 meeting, each tagged with who proposed it and the board's recommendation.
Disclaimer

The opinions and information contained herein have been obtained or derived from sources believed to be reliable, but Boardroom Alpha cannot guarantee its accuracy and completeness, and that of the opinions based thereon.

This report contains opinions and is provided for informational purposes only – it does not constitute investment, legal or tax advice. You should not rely solely upon the research herein for purposes of transacting securities or other investments, and you are encouraged to conduct your own research and due diligence, and to seek the advice of a qualified securities professional before you make any investment.

None of the information contained in this report constitutes, or is intended to constitute a recommendation by Boardroom Alpha of any particular security or trading strategy or a determination by Boardroom Alpha that any security or trading strategy is suitable for any specific person. To the extent any of the information contained herein may be deemed to be investment advice, such information is impersonal and not tailored to the investment needs of any specific person.

No representation or warranty, expressed or implied, is made on behalf of Boardroom Alpha as to the accuracy or completeness of the information contained herein. Boardroom Alpha does not accept any liability for any direct, indirect or consequential loss or damage suffered by any person as a result of relying on all or any part of this research and any liability is expressly disclaimed.

Full disclaimer